Cargando…

SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria

Since December 2019 the world has been dealing with a severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic. The first SARS-CoV-2 vaccine was made available in Europe at the end of 2020. 202 volunteers from the vicinity of the University of Applied Sciences Wiener Neustadt took...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mara, Elisabeth, Mader, Tobias, Gratzer, Johannes, Hochegger, Stefanie, Pekar, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472700/ https://www.ncbi.nlm.nih.gov/pubmed/38013972 http://dx.doi.org/10.1016/j.clicom.2022.08.001

Ejemplares similares

Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort
por: Mara, Elisabeth, et al.
Publicado: (2021)

Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria
por: Redlberger-Fritz, Monika, et al.
Publicado: (2021)

Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria
por: Lehmann, Jens, et al.
Publicado: (2021)

Heterogeneous magnitude of immunological memory to SARS‐CoV‐2 in recovered individuals
por: Mazzoni, Alessio, et al.
Publicado: (2021)

Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection
por: Chiarini, Marco, et al.
Publicado: (2020)

Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Long-term observation of antibody titers against SARS-CoV-2 following vaccination
por: Sugiyama, Kazuo, et al.
Publicado: (2022)

Autochthonous Dirofilaria repens in Austria
por: Silbermayr, Katja, et al.
Publicado: (2014)

Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection
por: Vicenti, Ilaria, et al.
Publicado: (2021)

Transplacental transfer of SARS-CoV-2 antibodies in recovered and BNT162b2-vaccinated patients
por: Treger, Sharon, et al.
Publicado: (2022)

A single dose of COVID-19 vaccine induces a strong T cell and B cell response in healthcare professionals recovered from SARS-CoV-2 infection
por: Laranjeira, Paula, et al.
Publicado: (2022)

Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters
por: Chillon, Thilo Samson, et al.
Publicado: (2023)

Radical prostatectomies in Austria, 1997–2004
por: Haidinger, Gerald, et al.
Publicado: (2008)

Update on the management of Barrett’s esophagus in Austria
por: Riegler, M., et al.
Publicado: (2017)

Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects
por: Ferrari, Davide, et al.
Publicado: (2021)

Vaccine-induced neutralizing antibodies against SARS-CoV-2 Omicron variant isolated in Osaka, Japan
por: Hiroi, Satoshi, et al.
Publicado: (2023)

Longitudinal monitoring of SARS-CoV-2 spike protein-specific antibody responses in Lower Austria
por: Rebholz, Heike, et al.
Publicado: (2022)

Vaccination against SARS-CoV-2 in adults with a diagnosis of cancer: a short review
por: Huf, Waltraud Elisabeth, et al.
Publicado: (2023)

Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects
por: Huynh, Angela, et al.
Publicado: (2021)

A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination
por: Liu, Jia, et al.
Publicado: (2021)

SARS‐CoV‐2 re‐infection risk in Austria
por: Pilz, Stefan, et al.
Publicado: (2021)

Tear antibodies to SARS‐CoV‐2: implications for transmission
por: Selva, Kevin J, et al.
Publicado: (2021)

Predictors of vaccine hesitancy during the COVID-19 pandemic in Austria: A population-based cross-sectional study
por: Till, Benedikt, et al.
Publicado: (2022)

Determining the impact of vaccination on SARS-CoV-2 RT-PCR cycle threshold values and infectious viral titres
por: Peterson, Katherine L., et al.
Publicado: (2023)

Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity
por: Jonczyk, Rebecca, et al.
Publicado: (2022)

Period prevalence of SARS-CoV-2 infections and willingness to vaccinate in Swiss elite athletes
por: Schmid, Michael Johannes, et al.
Publicado: (2022)

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
por: Shen, Xiaoying, et al.
Publicado: (2021)

An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines
por: Liu, Fei, et al.
Publicado: (2022)

Seroconversion panels demonstrate anti-SARS-CoV-2 antibody development after administration of the mRNA-1273 vaccine
por: Belda, Francisco, et al.
Publicado: (2022)

Skin-patch delivered subunit vaccine induces broadly neutralising antibodies against SARS-CoV-2 variants of concern
por: McMillan, Christopher L.D., et al.
Publicado: (2022)

IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
por: Fernandes-Siqueira, Lorena O., et al.
Publicado: (2022)

Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

Dermatitis linearis outbreak associated with Paederus balcanicus in Austria
por: Bakran-Lebl, Karin, et al.
Publicado: (2022)

REGEN‐COV antibody combination in patients with lymphoproliferative malignancies and SARS‐CoV‐2 infection
por: Bronstein, Yotam, et al.
Publicado: (2022)

Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2
por: Casado, José L., et al.
Publicado: (2022)

Previous SARS‐CoV‐2 infection or a third dose of vaccine elicited cross‐variant neutralising antibodies in vaccinated solid‐organ transplant recipients
por: Chang, Chih‐Chao, et al.
Publicado: (2022)

Genetic diversity of Fasciola hepatica in Austria
por: Husch, Christian, et al.
Publicado: (2020)

Assessment of commercial SARS-CoV-2 antibody assays, Jamaica
por: Butterfield, Tiffany R., et al.
Publicado: (2021)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 among healthcare workers
por: Sansone, Emanuele, et al.
Publicado: (2021)

1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19
por: Patel, M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nbohil368a00h2oe6tvojr4mp2